Clinical Trial Update: GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence

View source ↗

Summary

Real-world study evaluating embolism prevention in non-valvular atrial fibrillation patients treated with rivaroxaban, with involvement of general practitioners…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Japan Cardiovascular Research Foundation | Conditions: Atrial Fibrillation | Status: UNKNOWN